Galera Therapeutics, Inc. Announces Annual Meeting Date and Deadline for Stockholder Proposals

Galera Therapeutics, Inc. has scheduled its Combined 2025 and 2026 Annual Meeting of Stockholders for May 8, 2026. Due to the meeting date being more than 60 days after the anniversary of the 2025 Annual Meeting, the company is announcing the deadline for stockholders wishing to submit proposals or director nominations outside of the company's proxy materials. Such submissions must comply with the company's Amended and Restated Bylaws and be received by the Secretary, Joel Sussman, at the principal executive office by April 13, 2026. For proposals intended for inclusion in the company's proxy materials under Rule 14a-8, they must be received by April 13, 2026, which the company deems a reasonable time before printing and distributing proxy materials. Stockholders intending to solicit proxies for director nominees other than the company's must also provide notice by April 13, 2026, in accordance with Rule 14a-19.